Covetrus to Present at the J.P. Morgan 38th Annual Healthcare Conference

Covetrus将出席J.P.Morgan第38届年度保健会议

2020/01/03 13:30  Business Wire

Covetrus™ (NASDAQ: CVET), a global leader in animal-health technology and services, today announced that the Company will be participating in theJ.P. Morgan 38th Annual Healthcare Conferencein San Francisco, CA.

Covetrus acting president and chief executive officer Benjamin Wolin is scheduled to present on Wednesday, January 15, 2020 at 9:30 a.m. Pacific Time. A live webcast of the presentation, as well as an archived recording, will be available on the Investor Relations section of the Company’s website athttps://ir.covetrus.com/investors/events-and-presentations.

About Covetrus

Covetrus is a global animal-health technology and services company dedicated to empowering veterinary practice partners to drive improved health and financial outcomes. We’re bringing together products, services and technology into a single platform that connects our customers to the solutions and insights they need to work best. Our passion for the well-being of animals and those who care for them drives us to advance the world of veterinary medicine. Covetrus is headquartered in Portland, Maine, with more than 5,500 employees, serving over 100,000 customers around the globe. Learn more atcovetrus.com.

Forward-Looking Statements

This press release contains certain statements that are forward-looking within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and that involve risks and uncertainties, including statements about our plans, objectives, expectations, and intentions. Such statements are subject to numerous risks and uncertainties. Factors that could adversely affect our business and prospects are set forth in our public filings with the Securities and Exchange Commission. Our forward-looking statements are based on current beliefs and expectations of our management team and, except as required by law, we undertake no obligations to make any revisions to the forward-looking statements contained in this release or to update them to reflect events or circumstances occurring after the date of this release, whether as a result of new information, future developments or otherwise. Investors are cautioned not to place undue reliance on these forward-looking statements.

View source version on businesswire.com:https://www.businesswire.com/news/home/20200103005015/en/

Contacts

Nicholas Jansen, Investor Relations

nicholas.jansen@covetrus.com| (207) 550-8106

Kiní Schoop, Public Relations

kini.schoop@covetrus.com| (207) 550-8018

动物卫生技术和服务领域的全球领先者covetrus™(纳斯达克市场代码:cvet)今天宣布,该公司将参加在加利福尼亚州旧金山举行的摩根摩根第38届年度保健会议。

Covetrus公司代理总裁兼首席执行官本杰明·沃林定于2020年1月15日星期三上午9:30出席会议。太平洋时间。将在公司网站athttps://ir.covetrus.com/investors/events-and-presentations.的投资者关系部分提供现场直播以及存档记录

关于Covetrus

Covetrus是一家全球动物卫生技术和服务公司,致力于授权兽医实践伙伴推动改善健康和财务结果。我们把产品、服务和技术整合到一个单一的平台上,将我们的客户与他们所需要的解决方案和见解联系起来,使他们能够最佳地工作。我们对动物福利的热情,以及那些关心动物的人,推动着我们推进兽医学的世界。Covetrus公司总部设在缅因州波特兰,拥有5500多名员工,为全球10万多名客户提供服务。了解更多的atcovetrus.com。

前瞻性陈述

本新闻稿载有某些经修正的1933年“证券法”第27A条和经修正的1934年“证券交易法”第21E条所指的前瞻性陈述,涉及风险和不确定性,包括关于我们的计划、目标、预期和意图的陈述。这种说法受到许多风险和不确定因素的影响。我们在向证券交易委员会提交的公开文件中列出了可能对我们的业务和前景产生不利影响的因素。我们的前瞻性陈述是基于我们管理团队目前的信念和期望,并且,除法律要求外,我们没有义务对本新闻稿中包含的前瞻性声明进行任何修改,或更新这些声明以反映本新闻稿发布日期之后发生的事件或情况,无论是由于新的信息、未来的发展还是其他原因。投资者被告诫不要过分依赖这些前瞻性的声明。

在businesswire.com:https://www.businesswire.com/news/home/20200103005015/en/上查看源代码版本

接触

Nicholas Jansen,投资者关系

nicholas.jansen@covetrus.com(207)550-8106

KiníSchoop,公共关系

kini.choop@covetrus.com(207)550-8018

免责声明:中文翻译由腾讯翻译君提供支持,富途对翻译信息的准确性或可靠性所造成的任何损失不承担任何责任。

风险提示:上文所示之作者或者嘉宾的观点,都有其特定立场,投资决策需建立在独立思考之上。富途将竭力但却不能保证以上内容之准确和可靠,亦不会承担因任何不准确或遗漏而引起的任何损失或损害。